COVID-19 Biomarker Database

This ‘Open-Access’ resource is excerpted from our GOBIOM platform – the world’s largest biomarker intelligence database. The database is a compilation of manually curated biomarkers from published clinical trials, evaluating potential drugs or biologics for the treatment of SARS-CoV-2.

The database additionally includes information on FDA-NIH recommended BEST (Biomarkers, EndpointS and other Tools) classification of biomarkers, supported with direct links to the referenced literature. The database is updated regularly with COVID-19 relevant clinical trials published in clinicaltrials.gov.

Access here